Keebeck Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$394K Buy
4,512
+489
+12% +$46.8K 0.04% 263
2025
Q4
$389K Buy
4,023
+180
+5% +$17.5K 0.04% 257
2025
Q3
$369K Sell
3,843
-25
-0.6% -$2.3K 0.04% 267
2025
Q2
$340K Sell
3,868
-118
-3% -$10K 0.04% 266
2025
Q1
$361K Buy
3,986
+522
+15% +$46.7K 0.05% 197
2024
Q4
$279K Buy
3,464
+233
+7% +$20.2K 0.04% 221
2024
Q3
$293K Sell
3,231
-199
-6% -$16.7K 0.04% 214
2024
Q2
$272K Hold
3,430
0.04% 228
2024
Q1
$301K Hold
3,430
0.04% 237
2023
Q4
$285K Sell
3,430
-36
-1% -$2.74K 0.05% 233
2023
Q3
$274K Buy
3,466
+65
+2% +$5.44K 0.05% 214
2023
Q2
$302K Sell
3,401
-28
-0.8% -$2.41K 0.04% 214
2023
Q1
$279K Sell
3,429
-836
-20% -$68.1K 0.04% 214
2022
Q4
$334K Buy
4,265
+42
+1% +$3.4K 0.06% 185
2022
Q3
$344K Hold
4,223
0.07% 178
2022
Q2
$382K Hold
4,223
0.07% 173
2022
Q1
$471K Hold
4,223
0.08% 165
2021
Q4
$440K Sell
4,223
-300
-7% -$34.7K 0.08% 158
2021
Q3
$570K Sell
4,523
-533
-11% -$69K 0.11% 131
2021
Q2
$630K Sell
5,056
-100
-2% -$12.6K 0.09% 148
2021
Q1
$612K Hold
5,156
0.1% 144
2020
Q4
$607K Buy
5,156
+812
+19% +$89.4K 0.11% 135
2020
Q3
$453K Buy
4,344
+248
+6% +$24.9K 0.09% 137
2020
Q2
$377K Hold
4,096
0.12% 127
2020
Q1
$371K Buy
4,096
+2,100
+105% +$223K 0.15% 110
2019
Q4
$227K Buy
+1,996
New +$219K 0.07% 135

Other funds holding MDT

Keebeck Wealth Management's MDT Position: Q1 2026 in Review

Keebeck Wealth Management increased its Medtronic (MDT) stake by 12% in Q1 2026, buying an estimated $46.8K and bringing the position to 4,512 shares worth $394K. The position accounts for 0.04% of the portfolio, ranked #263.

Keebeck Wealth Management first reported a position in MDT in Q4 2019 and has held it in 26 quarters since. The position peaked at $630K in Q2 2021. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Keebeck Wealth Management held 4,512 shares of Medtronic worth $394K as of Q1 2026.
  • Keebeck Wealth Management bought 489 Medtronic shares in Q1 2026, an estimated $46.8K.
  • Medtronic made up 0.04% of Keebeck Wealth Management's portfolio in Q1 2026, its #263 holding.
  • Keebeck Wealth Management first reported a position in Medtronic in Q4 2019 and has held it in 26 quarters since.
  • Keebeck Wealth Management's Medtronic position peaked at $630K in Q2 2021.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Keebeck Wealth Management's 13F filing for Q1 2026, filed 14 May 2026.